Exanthem
MONDO:0006547A skin disease characterized by widespread, often symmetrical skin eruption that typically occurs acutely in association with a systemic disease, especially infectious or immune-mediated conditions.
Also known as: cutaneous eruption, rash, skin eruption, skin rash, exanthem, exanthem (disease), exanthema
26 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Newer antifungal cream may beat old standard for skin fungus
⭐️ CURE ⭐️ Not yet recruitingThis study tests whether a newer antifungal cream (luliconazole) works better than the standard treatment (ketoconazole) for pityriasis versicolor, a common fungal skin infection that causes light or dark patches. About 86 adults with the infection will use one of the two creams …
Phase: PHASE4 • Sponsor: PAEC General Hospital, Islamabad • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 08:10 UTC
-
Can a cancer drug wake up immune cells to beat HIV-Related infections?
Disease control Not yet recruitingThis study tests a drug called Sintilimab, which is normally used for cancer, to see if it can help people with HIV who have infections that won't go away with standard treatment. The drug works by 'waking up' exhausted immune cells. Fifty adults with HIV and a hard-to-treat infe…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Cream or pill? new study tests best way to treat fungal skin infection
Disease control Not yet recruitingThis study compares two treatments for pityriasis versicolor, a fungal skin infection that causes discolored patches. One group will apply a clotrimazole cream twice daily for two weeks, while the other takes itraconazole pills daily for five days. The trial aims to see which app…
Phase: PHASE1, PHASE2 • Sponsor: Combined Military Hospital Abbottabad • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug aimed at calming the itch of prurigo nodularis enters human testing
Symptom relief Not yet recruitingThis Phase 2 study tests lebrikizumab (Ebglyss) in 15 adults with moderate-to-severe prurigo nodularis, a skin condition causing intense itching and hard bumps. Participants receive injections every two weeks for 24 weeks. The main goals are to measure how much itching decreases …
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Shorter or longer? study tests best duration for fungal shampoo treatment
Symptom relief Not yet recruitingThis study looks at whether using ketoconazole 2% shampoo for seven days works better than using it for three days to treat pityriasis versicolor, a common fungal skin condition that causes discolored patches. About 76 people aged 12 and older with confirmed infection will be ran…
Phase: PHASE4 • Sponsor: Fakultas Kedokteran Universitas Indonesia • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC